Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup -- Ignore unavailable to you. Want to Upgrade?

To: Bocor who wrote (34442)	9/6/2001 7:35:29 AM
From: GREENLAW4-7	Read Replies (1) \| Respond to of 37746

Going long for SCALPS! Too much shorting..should see reverse on INTC news tomorrow! Daytrading QLGC, BRCD, HGSI and MYGN. Not brave enought to stay too short! LOL Looking for technical bounce perhaps 3pm today through monday!

To: Bocor who wrote (34442)	9/6/2001 9:06:36 AM
From: Frederick Langford	Read Replies (2) \| Respond to of 37746

IDPH had positive mention this morning at Lehman. They indicate that Zevalin will be reviewed by an FDA advisory panel on September 11. They feel that there is a 75% or greater of a positive outcome and forecast revenues from the product of $70 million in the first year. Additionally, the weaker dollar should help the Pharmaceutical areas. The sector currently has a 12% premium to the S&P and is undervalued if you compare it with the historical 27% premium for the group. Fred